BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33421131)

  • 21. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
    Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
    Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas.
    Psarras K; Ueda M; Yamamura T; Ozawa S; Kitajima M; Aiso S; Komatsu S; Seno M
    Protein Eng; 1998 Dec; 11(12):1285-92. PubMed ID: 9930679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.
    Lorimer IA; Keppler-Hafkemeyer A; Beers RA; Pegram CN; Bigner DD; Pastan I
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14815-20. PubMed ID: 8962138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Analyses of An Epidermal Growth Factor Receptor-Specific Single-Chain Fragment Variable via An In Silico Approach.
    Mahgoub EO; Kulkarni S
    J Vis Exp; 2023 Nov; (201):. PubMed ID: 38009747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and Conjugation of Truncated Recombinant Diphtheria Toxin to VEGFR-2 Specific Nanobody and Evaluation of its Cytotoxic Effect on PC-3 Cell Line.
    Shajari S; Farajollahi MM; Behdani M; Tarighi P
    Mol Biotechnol; 2022 Nov; 64(11):1218-1226. PubMed ID: 35478310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
    Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
    Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
    Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
    Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribonucleases as novel chemotherapeutics : the ranpirnase example.
    Lee JE; Raines RT
    BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
    Heitner T; Moor A; Garrison JL; Marks C; Hasan T; Marks JD
    J Immunol Methods; 2001 Feb; 248(1-2):17-30. PubMed ID: 11223066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering Human Pancreatic RNase 1 as an Immunotherapeutic Agent for Cancer Therapy Through Computational and Experimental Studies.
    Nassiri M; Ghovvati S; Gharouni M; Tahmoorespur M; Bahrami AR; Dehghani H
    Protein J; 2024 Apr; 43(2):316-332. PubMed ID: 38145445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
    Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro.
    Mironova KE; Proshkina GM; Ryabova AV; Stremovskiy OA; Lukyanov SA; Petrov RV; Deyev SM
    Theranostics; 2013; 3(11):831-40. PubMed ID: 24312153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.
    Kiesgen S; Arndt MAE; Körber C; Arnold U; Weber T; Halama N; Keller A; Bötticher B; Schlegelmilch A; Liebers N; Cremer M; Herold-Mende C; Dyckhoff G; Federspil PA; Jensen AD; Jäger D; Kontermann RE; Mier W; Krauss J
    Cancer Lett; 2015 Feb; 357(1):364-373. PubMed ID: 25434798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.
    Rezaie E; Amani J; Bidmeshki Pour A; Mahmoodzadeh Hosseini H
    Eur J Pharmacol; 2020 Mar; 870():172912. PubMed ID: 31926992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma.
    Huang S; Jiang C; Zhang H; Bell T; Guo H; Liu Y; Yao Y; Zeng D; Ahmed M; Nomie K; Zhang L; Wang M
    Blood Cancer J; 2018 Mar; 8(3):33. PubMed ID: 29559616
    [No Abstract]   [Full Text] [Related]  

  • 37. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
    Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40).
    Shilova ON; Souslova EA; Pilunov AM; Deyev SM; Petrov RV
    Dokl Biochem Biophys; 2016 Nov; 471(1):450-453. PubMed ID: 28058684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy.
    Nassiri M; Behnam-Rasouli R; Vakili-Azghandi M; Gopalan V; Dolati P; Nourmohammadi R
    Life Sci; 2022 Jan; 289():120222. PubMed ID: 34902436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.
    Itai S; Yamada S; Kaneko MK; Chang YW; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):272-281. PubMed ID: 29090976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.